Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,909 | 4,772 | 3,252 | 6,275 | -586 |
| Depreciation Amortization | -5,201 | -2,969 | -1,618 | -230 | 910 |
| Income taxes - deferred | 6,198 | 3,469 | 2,014 | 1,130 | 713 |
| Accounts receivable | 4,129 | -199 | 8,901 | -1,089 | 2,982 |
| Accounts payable and accrued liabilities | -14,315 | -14,035 | -10,791 | 11,793 | 15,070 |
| Other Working Capital | -3,567 | 3,212 | 22,040 | 6,074 | 7,423 |
| Other Operating Activity | 24,380 | 24,333 | 8,005 | 8,031 | -3,944 |
| Operating Cash Flow | $16,533 | $18,583 | $31,803 | $31,984 | $22,568 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | -106 | -51 | -679 | -416 |
| Purchase Of Investment | -457,628 | -410,979 | -163,045 | -349,258 | -344,949 |
| Sale Of Investment | 489,485 | 407,485 | 350,390 | 399,862 | 319,862 |
| Investing Cash Flow | $31,727 | $-3,600 | $187,294 | $49,925 | $-25,503 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 734 | 129 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $734 | $129 |
| Exchange Rate Effect | -103 | 19 | 45 | 265 | 82 |
| Beginning Cash Position | 135,498 | 135,498 | 135,498 | 52,590 | 52,590 |
| End Cash Position | 183,655 | 150,500 | 354,640 | 135,498 | 49,866 |
| Net Cash Flow | $48,157 | $15,002 | $219,142 | $82,908 | $-2,724 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,533 | 18,583 | 31,803 | 31,984 | 22,568 |
| Capital Expenditure | -130 | -106 | -51 | -679 | -416 |
| Free Cash Flow | 16,403 | 18,477 | 31,752 | 31,305 | 22,152 |